295 related articles for article (PubMed ID: 33247159)
1. Pharmacological characterisation of novel adenosine A
Barkan K; Lagarias P; Stampelou M; Stamatis D; Hoare S; Safitri D; Klotz KN; Vrontaki E; Kolocouris A; Ladds G
Sci Rep; 2020 Nov; 10(1):20781. PubMed ID: 33247159
[TBL] [Abstract][Full Text] [Related]
2. Insights to the Binding of a Selective Adenosine A
Lagarias P; Barkan K; Tzortzini E; Stampelou M; Vrontaki E; Ladds G; Kolocouris A
J Chem Inf Model; 2019 Dec; 59(12):5183-5197. PubMed ID: 31725294
[TBL] [Abstract][Full Text] [Related]
3. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
4. Structural Characterization of Agonist Binding to an A
Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A
J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843
[TBL] [Abstract][Full Text] [Related]
5. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
[TBL] [Abstract][Full Text] [Related]
6. Effect of Nitrogen Atom Substitution in A
Azuaje J; Jespers W; Yaziji V; Mallo A; Majellaro M; Caamaño O; Loza MI; Cadavid MI; Brea J; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
J Med Chem; 2017 Sep; 60(17):7502-7511. PubMed ID: 28792759
[TBL] [Abstract][Full Text] [Related]
7. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
8. Development of Covalent, Clickable Probes for Adenosine A
Trinh PNH; Chong DJW; Leach K; Hill SJ; Tyndall JDA; May LT; Vernall AJ; Gregory KJ
J Med Chem; 2021 Jun; 64(12):8161-8178. PubMed ID: 34120444
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.
Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A
J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
[TBL] [Abstract][Full Text] [Related]
11. Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.
Ranganathan A; Stoddart LA; Hill SJ; Carlsson J
J Med Chem; 2015 Dec; 58(24):9578-90. PubMed ID: 26592528
[TBL] [Abstract][Full Text] [Related]
12. Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor.
Haeusler D; Grassinger L; Fuchshuber F; Hörleinsberger WJ; Höftberger R; Leisser I; Girschele F; Shanab K; Spreitzer H; Gerdenitsch W; Hacker M; Wadsak W; Mitterhauser M
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):928-39. PubMed ID: 25739834
[TBL] [Abstract][Full Text] [Related]
13. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S
J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825
[TBL] [Abstract][Full Text] [Related]
14. Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A
Lee Y; Hou X; Lee JH; Nayak A; Alexander V; Sharma PK; Chang H; Phan K; Gao ZG; Jacobson KA; Choi S; Jeong LS
J Med Chem; 2021 Sep; 64(17):12525-12536. PubMed ID: 34435786
[TBL] [Abstract][Full Text] [Related]
15. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
[TBL] [Abstract][Full Text] [Related]
16. A3 adenosine receptor: homology modeling and 3D-QSAR studies.
Almerico AM; Tutone M; Pantano L; Lauria A
J Mol Graph Model; 2013 May; 42():60-72. PubMed ID: 23567933
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
Gessi S; Varani K; Merighi S; Morelli A; Ferrari D; Leung E; Baraldi PG; Spalluto G; Borea PA
Br J Pharmacol; 2001 Sep; 134(1):116-26. PubMed ID: 11522603
[TBL] [Abstract][Full Text] [Related]
18. Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure-Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations.
Stampelou M; Suchankova A; Tzortzini E; Dhingra L; Barkan K; Lougiakis N; Marakos P; Pouli N; Ladds G; Kolocouris A
J Med Chem; 2022 Oct; 65(19):13305-13327. PubMed ID: 36173355
[TBL] [Abstract][Full Text] [Related]
19. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
van Galen PJ; van Bergen AH; Gallo-Rodriguez C; Melman N; Olah ME; IJzerman AP; Stiles GL; Jacobson KA
Mol Pharmacol; 1994 Jun; 45(6):1101-11. PubMed ID: 8022403
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Optimization of Coumarin hA
Matos MJ; Vilar S; Vazquez-Rodriguez S; Kachler S; Klotz KN; Buccioni M; Delogu G; Santana L; Uriarte E; Borges F
J Med Chem; 2020 Mar; 63(5):2577-2587. PubMed ID: 31738058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
